Arcus Biosciences’ quemliclustat receives US FDA orphan drug designation to treat pancreatic cancer: Hayward, California Tuesday, July 15, 2025, 13:00 Hrs [IST] Arcus Bioscience ...

People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of cancer, often at ages younger than typically seen in the general population, ...

The Foundation also awarded Continuation Grants to three Damon Runyon Clinical Investigators, totaling $1,000,000 in additional funding. The Continuation Grants are designed to support Clinical ...

Tumors can destroy the blood vessels of muscles even when the muscles are nowhere close to the tumor. That is the key finding ...

Quest Diagnostics Incorporated (NYSE:DGX) is one of the 7 most undervalued pot stocks to buy according to analysts.

When researchers used a gene therapy to restore blood vessel health by counteracting the effects of Activin-A, they were able to prevent muscle loss.

A test developed by a Madison company to better track cancer DNA in the blood stream will now be covered by Medicare.

The test claims to analyse epigenomic and genomic data from circulating, cell-free DNA obtained from a simple blood draw.

Methylation changes in microbiome-derived cfRNA enable more accurate CRC diagnosis than traditional DNA or abundance-based ...

The San Diego-based firm said that it is transitioning beyond laboratory-developed tests and expanding access to its tests for the detection of early-stage cancers.

Could a sea cucumber sugar transform cancer care? A new study reveals its enzyme-blocking potential and safer profile ...